Leona Health, a healthtech based in Mexico City and Silicon Valley, announced on 17 December 2025 a USD 14 million seed round led by Andreessen Horowitz. It is a Series A-sized seed for a digital health company founded in Mexico, and its amount relative to a 13-person team says more about global funds’ appetite for clinical AI than about the state of the company.
The transaction
Seed round of USD 14 million. Lead investor: Andreessen Horowitz. General Catalyst, Accel, Kate Ryder, chief executive of Maven Clinic, David Vélez, founder of Nubank, and Simón Borrero, founder of Rappi, participated. Valuation, instrument and other terms were not disclosed.
The company was founded by Caroline Merin, former chief operating officer of Rappi and the first general manager of Uber Eats in Latin America. The product is an artificial intelligence copilot that helps physicians manage patient messages on WhatsApp: it identifies urgent requests, suggests responses and routes administrative messages to nurses or other staff. It operates in 14 countries in the region and 22 specialties with a team of 13; the company states it saves up to three hours a day per physician. Proceeds will go to product development and new markets; the next launch is an autonomous agent for scheduling and patient intake.
Value drivers
The founder. An operator who scaled two consumer platforms in the region is, in our reading, the main reason for the round’s size. Funds are paying for execution capacity in a market where distribution to the independent physician is the bottleneck.
The channel. In Latin America the physician-patient relationship already happens on WhatsApp. Building on that channel removes the cost of changing habits and explains how 14 countries are covered by 13 people.
Physician time as the unit of value. Up to three hours a day recovered is the metric that supports the product’s price. It is a company figure, not audited; the business model will depend on converting it into willingness to pay by the physician or the clinic.
Market timing. Six months later, Andreessen Horowitz led Telepatia’s USD 33 million Series A, another AI clinical platform with a presence in Mexico. In our reading, the fund is building a regional thesis on AI at the point of care, and Leona is its bet on the independent physician.
What the market is signalling
For Mexican healthtechs, the message is that top-tier US funds come in at seed when the founder and the AI thesis are clear, without waiting for revenue metrics. The cost of that signal is the benchmark it sets: a USD 14 million seed fixes Series A expectations that very few local companies will be able to show within 18 months.
For clinics, insurers and hospital networks in Mexico, a product that installs itself in the physician’s WhatsApp competes for the same relationship they want to digitise. For founders with practice-management products, the local buyer or strategic partner will appear sooner than expected if adoption is real.
G2’s reading for a mandate
A round of this profile is prepared around the founder and evidence of usage, not around a five-year financial model. For a later Series A, however, the investment committee will ask for retention per physician, revenue per specialty and acquisition cost per country. Our preparation of a clinical AI round starts by defining those metrics from seed, so that the next competitive process does not depend on the narrative.
Sources
- LatamList, 17 December 2025: Leona Health raises $14M seed round
- Startups Latam, 29 December 2025: Healthtech mexicana levanta US$14 millones para transformar la atención médica en Latinoamérica
- a16z, 17 June 2026: Investing in Telepatia